Trial Profile

A multicenter, open-label, phase 2 study of S-588410 as maintenance monotherapy after first-line platinum-containing chemotherapy in patients with advanced and/or metastatic bladder cancer

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 16 Sep 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Asudemotide (Primary)
Indications Bladder cancer; Carcinoma; Urogenital cancer
Focus Adverse reactions; Therapeutic Use
Sponsors Shionogi

Most Recent Events

13 Feb 2021 Results presented at the 2021 Genitourinary Cancers Symposium
11 Apr 2019 Status changed from active, no longer recruiting to completed.
03 Mar 2019 This has been completed in UK, according to European Clinical Trials Database.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com